Prefilled Syringes Market - PowerPoint PPT Presentation

About This Presentation
Title:

Prefilled Syringes Market

Description:

The global prefilled syringes market size achieved a valuation of US$ 7,742.9 million in 2022. It is expected to experience remarkable growth, reaching an estimated value of US$ 20,167.8 million by 2032. This growth trajectory reflects a robust projected compound annual growth rate (CAGR) of 10.0% from 2022 to 2032. – PowerPoint PPT presentation

Number of Views:1
Slides: 4
Provided by: nainad
Category: Other
Tags:

less

Transcript and Presenter's Notes

Title: Prefilled Syringes Market


1
The global prefilled syringes market size
achieved a valuation of US 7,742.9 million in
2022. It is expected to experience remarkable
growth, reaching an estimated value of US
20,167.8 million by 2032. This growth trajectory
reflects a robust projected compound annual
growth rate (CAGR) of 10.0 from 2022 to
2032. Leading the charge in this market expansion
is North America, poised to make a significant
contribution, accounting for over 35 of the
overall market growth during the evaluation
period. Download a Sample Copy of This Report
https//www.factmr.com/connectus/sample?flagSrep
id603 In the ever-evolving landscape of
healthcare, the demand for innovative drug
delivery methods has reached an all-time high.
Among the many solutions available, prefilled
syringes have emerged as a promising option,
revolutionizing the way medications are
administered. The Rise of Prefilled
Syringes Prefilled syringes are precisely what
their name suggests syringes filled with a
specific dose of medication before use. These
ready-to-administer syringes have gained
significant popularity for several compelling
reasons. First and foremost is their ease of use.
Prefilled syringes simplify the medication
process, eliminating the need for patients or
healthcare professionals to draw up the correct
dosage from vials or ampoules manually. This not
only reduces the risk of dosage errors but also
enhances patient compliance, particularly among
those who may have difficulty handling
traditional syringes. Moreover, prefilled
syringes are airtight and tamper-evident,
ensuring the sterility and integrity of the
medication until the moment of injection. This
feature is particularly crucial for biologics and
vaccines, which are sensitive to contamination
and require precise dosing. The Growing
Demand Several factors are driving the
exponential growth of the global prefilled
syringes market. 1. Rise in Chronic Diseases
The increasing prevalence of chronic diseases,
such as diabetes, rheumatoid arthritis, and
multiple sclerosis, has led to a higher demand
for self-administered medications. Prefilled
syringes empower patients to manage their
conditions conveniently and safely. 2.
Biopharmaceutical Boom The development and
approval of biologic drugs have surged in recent
years. These complex, high-value therapies often
require precise dosing and are best delivered
through prefilled syringes, as they reduce the
risk of contamination and ensure accurate
administration. 3. Vaccine Distribution The
global fight against infectious diseases, most
notably the COVID-19 pandemic, has driven vaccine
production and distribution to unprecedented
levels. Prefilled syringes have played a crucial
role in mass vaccination campaigns due to their
ease of use and efficient dosing. 4. Aging
Population As the global population ages, there
is an increased need for therapies and
medications tailored to the elderly. Prefilled
syringes simplify medication administration for
older patients, ensuring they receive the correct
dosage without relying on complex instructions.
2
Competitive Landscape
Prominent manufacturers in the prefilled syringes
industry include Becton Dickinson and Company,
Terumo Medical Corporation, Baxter International
Inc., Gerresheimer, B. Braun Melsungen AG,
Catalent Inc., Elcam Medical, Nipro Corporation,
SCHOTT AG, and Weigao Group, along with West
Pharmaceutical Services Inc. These industry
leaders are committed to producing sustainable
products that enhance safety and efficiency while
concurrently reducing waste, energy consumption,
and environmental impacts. Moreover, they are
actively engaging in strategic alliances and
collaborations with their competitors to bolster
and fortify their global market presence. In
January 2022, Owen Mumford made a significant
announcement regarding the market launch of
UniSafe, a 1 ml safety device designed for
prefilled syringes. This innovation is aimed at
preventing accidental activation and drug
leakage, further establishing the company's
commitment to safety. In October 2021, West
Pharmaceutical Services Inc. introduced the
NovaGuard SA Pro Safety System in India. This
system is a single-use accessory tailored for
prefilled 0.5mL staked needle syringes, adhering
to ISO standards and underlining the company's
dedication to advancing safety standards in the
industry. Segmentation of Prefilled Syringes
Industry Research By Function Type o Single
Chambered o Dual/Multi Chambered By Material
Type o Glass-based o Polymer-based By
Technology Type o Conventional o Safety By
End-user o Hospitals o Specialty Clinics o
Online Pharmacies o Other By Region o North
America o Latin America o Europe o East Asia o
South Asia ASEAN o Oceania o MEA Get
Customization on this Report https//www.factmr.c
om/connectus/sample?flagRCrep id603
Market Projections
3
Market analysts predict substantial growth for
the global prefilled syringes market in the
coming years. Factors such as the ongoing
development of new biologics, expanding
vaccination programs, and the quest for more
patient-centric healthcare solutions are expected
to fuel this expansion. Contact US Sales Office
11140 Rockville Pike Suite 400 Rockville, MD
20852 United States Tel 1 (628) 251-1583,
353-1-4434-232 Email sales_at_factmr.com
Write a Comment
User Comments (0)
About PowerShow.com